Seoul [South Korea], November 1 (ANI/Global Economic): A large number of consortiums of pharmaceutical-bio companies and research institutes to develop mRNA (messenger ribonucleic acid) vaccines are rapidly being established. As mRNA emerges as a new paradigm for vaccines, consortiums are ai